These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31888796)

  • 1. The Diagnosis and Treatment of Hypertriglyceridemia.
    Parhofer KG; Laufs U
    Dtsch Arztebl Int; 2019 Dec; 116(49):825-832. PubMed ID: 31888796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertriglyceridemia and cardiovascular risk reduction.
    Jacobson TA; Miller M; Schaefer EJ
    Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia: the importance of identifying patients at risk.
    Kushner PA; Cobble ME
    Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.
    Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D
    Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
    Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE; Tighe AP; Sadovsky R; Davidson MH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factor.
    Scholz M; Tselmin S; Fischer S; Julius U
    Atheroscler Suppl; 2015 May; 18():146-53. PubMed ID: 25936319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe hypertriglyceridemia : Diagnostics and new treatment principles].
    Kassner U; Dippel M; Steinhagen-Thiessen E
    Internist (Berl); 2017 Aug; 58(8):866-876. PubMed ID: 28516251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertriglyceridemia.
    Pejic RN; Lee DT
    J Am Board Fam Med; 2006; 19(3):310-6. PubMed ID: 16672684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids.
    Karalis DG
    Adv Ther; 2017 Feb; 34(2):300-323. PubMed ID: 27981496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hypertriglyceridemia: Common Questions and Answers.
    Oh RC; Trivette ET; Westerfield KL
    Am Fam Physician; 2020 Sep; 102(6):347-354. PubMed ID: 32931217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence.
    Maki KC; Bays HE; Dicklin MR
    J Clin Lipidol; 2012; 6(5):413-26. PubMed ID: 23009777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
    Stroes ESG; Susekov AV; de Bruin TWA; Kvarnström M; Yang H; Davidson MH
    J Clin Lipidol; 2018; 12(2):321-330. PubMed ID: 29289538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.
    Pirillo A; Catapano AL
    Drug Des Devel Ther; 2015; 9():2129-37. PubMed ID: 25914523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia-why, when and how should it be treated?
    Gouni-Berthold I; Krone W
    Z Kardiol; 2005 Nov; 94(11):731-9. PubMed ID: 16258774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypertriglyceridemia.
    Oh RC; Lanier JB
    Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertriglyceridemia: a review of current options.
    Vrablík M; Češka R
    Physiol Res; 2015; 64(Suppl 3):S331-40. PubMed ID: 26680666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is hypertriglyceridemia atherogenic?
    Roubille F; Sultan A; Huet F; Leclercq F; Macia JC; Gervasoni R; Delseny D; Akodad M; Roubille C
    Presse Med; 2018 Sep; 47(9):757-763. PubMed ID: 30262206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.